It is near a double bottom now in low .50's with RSI already near .30 and a bottoming forming stochastic with a MACD that is showing break out potential. But there is a slight risk to .40's. If it does that low, then by TZYM 'hand-over-fist'. This stock, and as you say CPRX are eventually headed higher. .80-1.00+ for both gonna happen. Both have enough cash for over a year and have good pharma assets with low outstanding share floats.